Literature DB >> 500302

Observations with the "Bi-flo" cannula (continuous, single-needle haemodialysis).

A Karátson, L Farkas, D Frang.   

Abstract

Observations with the double-lumen "Bi-flo" cannula in chronic intermittent haemodialysis are reported. On the evidence of urea and creatinine measurements, recirculation of blood corresponds to 7.9 and 6.1 per cent, respectively. In comparison with double-needle or single-needle dialysis, use of the double-lumen cannula does not affect the efficiency of dialysis to any notable degree. The advantages and shortcomings of the "Bi-flo" cannula with regard to the technique of dialysis are summed up.

Entities:  

Mesh:

Year:  1979        PMID: 500302     DOI: 10.1007/bf02081967

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  7 in total

1.  ONE-CANNULA HAEMODIALYSIS.

Authors:  E E TWISS
Journal:  Lancet       Date:  1964-11-21       Impact factor: 79.321

2.  Single-needle haemodialysis.

Authors:  A Karátson; J Juhász; J Markó; J Tatai
Journal:  Int Urol Nephrol       Date:  1976       Impact factor: 2.370

3.  Single puncture dialysis without auxilliary equipment.

Authors:  L Grimsrud; J A Lehman; D Scollard; R O Hickman
Journal:  Proc Eur Dial Transplant Assoc       Date:  1976

4.  Single needle dialysis.

Authors:  K F Kopp; C F Gutch; W J Kolff
Journal:  Trans Am Soc Artif Intern Organs       Date:  1972

5.  Dialysance of molecules of different size in reused Kiil, Ab-Gambro, and Rhône-Poulenc dialysers.

Authors:  P Kramer; D Matthaei; J G Go; H J Tönnis; F Scheler
Journal:  Br Med J       Date:  1972-05-06

6.  Single needle continuous flow haemodialysis without a control module.

Authors:  S T Boen; W A Haagsma-Schouten; R J Birnie
Journal:  Proc Eur Dial Transplant Assoc       Date:  1977

7.  Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula.

Authors:  M J Brescia; J E Cimino; K Appel; B J Hurwich
Journal:  N Engl J Med       Date:  1966-11-17       Impact factor: 91.245

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.